Statement of changes in beneficial ownership of securities



>




X0306


4


2021-05-10


0



0001624658


Allena Pharmaceuticals, Inc.


ALNA





0001389500


BRENNER LOUIS MD




C/O ALLENA PHARMACEUTICALS, INC.


ONE NEWTON EXECUTIVE PARK, SUITE 202


NEWTON


MA


02462






0


1


0


0


President and COO







Common Stock




2021-05-10






4


S


0











25215




1.11




D






203322






D







Common Stock




2021-05-10






4


M


0









83721








A






228537






D









Restricted Stock Units








2021-05-10






4


M


0









83721




0.00




D














Common Stock




83721






125582






D







The sale reported on this Form 4 was effected by the Reporting Person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units.


Each restricted stock unit represents a contingent right to receive one share of common stock.


40% shall vest on May 10, 2021 and the remaining 60% shall vest on November 10, 2021, subject to the Reporting Person's continued service through each vesting date.






/s/ Kevin Brennan, attorney-in-fact


2021-05-12





The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Allena Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Statement of acquisition of beneficial ownership by individuals - Jan. 25, 2022
Allena Pharmaceuticals Provides Clinical And Corporate Update ALLN-346, - Jan. 4, 2022

Auto Refresh

Feedback